Drew M. Pardoll
Johns Hopkins University
Public scientific profile · Unclaimed
Built from public scholarly sources. Expertise is inferred by ScienceWe from publications and has not been confirmed by the scientist.
Top expertise
Cancer Immunotherapy and Biomarkers
Strong evidence · 2 supporting papers · latest 2025
Occupational and environmental lung diseases
Strong evidence · 1 supporting paper · latest 2025
Pleural and Pulmonary Diseases
Strong evidence · 1 supporting paper · latest 2025
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Strong evidence · 1 supporting paper · latest 2025
Single-cell and spatial transcriptomics
Strong evidence · 1 supporting paper · latest 2025
Immune cells in cancer
Solid evidence · 1 supporting paper · latest 2025
Immune Cell Function and Interaction
Solid evidence · 1 supporting paper · latest 2026
Reliability and Agreement in Measurement
Supporting evidence · 1 supporting paper · latest 2025
Publications (5)
Novel Predictive Spatial Biomarker in Non-Small Cell Lung Carcinoma: The Diversity of Niches Unlocking Treatment Sensitivity (DONUTS)
2025DOIPMID 40832222
Perioperative nivolumab or nivolumab plus ipilimumab in resectable diffuse pleural mesothelioma: a phase 2 trial and ctDNA analyses
2025DOIPMID 40921804
Divergent Clinical and Immunologic Outcomes Based on STK11 Co-mutation Status in Resectable KRAS- Mutant Lung Cancers Following Neoadjuvant Immune Checkpoint Blockade
2024DOIPMID 39545922
Select intratumoral riboflavin-auxotrophic Enterococcus species enhance cell surface MR1 expression and MAIT TCR activation in lung cancer
2026DOIPMID 42611994
97 Statistical and systematic uncertainties affect biomarker reliability: a case study in multiplex immunofluorescence
2025DOI
Organizations in sourced records
Affiliation evidence only — not confirmed current employment.
- Johns Hopkins University
Source: OpenAlex · retrieved 2026-09-29